Patent expiry and costs for anti-cancer medicines for clinical use: expiry and costs anti-cancer medicines

Brian Godman, Claudia Wild, Alan Haycox

Research output: Contribution to journalEditorialpeer-review

81 Downloads (Pure)


Drs Brian Godman, Claudia Wild and Alan Haycox review the paper by Venkatesan et al on the patent expiry of (non-) tyrosine kinase inhibitors.
Original languageEnglish
Pages (from-to)1-3
Number of pages3
JournalGenerics and Biosimilars Initiative journal
Publication statusAccepted/In press - 17 Mar 2017


  • anti cancer medicines
  • medicine patents
  • tyrosine kinase inhibitors

Cite this